| The Key to Cell Motility  By Jason Socrates 
                    Bardi  Scientists at The Scripps Research Institute have described 
                    the regulatory mechanism of an important human protein called 
                    Rac that controls a number of biological processes and is 
                    directly implicated in several human diseases. 
                    Rac is involved in tumor growth and metastasis in cancer; 
                    it is important for the proper functioning of immune cells 
                    and is necessary for the innate immune response; it is required 
                    for neuronal function and has been implicated in neurological 
                    diseases and mental retardation. 
                    "Understanding the basic mechanism of how Rac activation 
                    is regulated," says Professor Gary Bokoch, "is a key to understanding 
                    [these sorts of diseases]." 
                    In an article appearing in the latest issue of the journal 
                    Molecular Cell, Bokoch and his colleagues Celine DerMardirossian 
                    and Andreas Schnelzer at Scripps Research have described the 
                    molecular mechanism whereby Rac activation is regulated by 
                    a molecule called Pak. 
                    The Rac-Pak Connection and Its Relevance to Disease Rac is one of the most important members of a family of 
                    proteins known as the Rho GTPases. This family of proteins 
                    binds to a small metabolic product called GTP, which acts 
                    as a critical regulator of Rho GTPase activity. This enables 
                    Rac to regulate a wide variety of cellular functions that 
                    span the entire gamut of a cell's life, from its initial growth 
                    and differentiation, to its movement and division, and finally 
                    to its death. They are important for gene expression, and 
                    they play crucial roles in the ability of innate immune cells 
                    to make lethal responses to bacterial infections, of skin 
                    cells to cover wounds during the healing process, of vascular 
                    cells to make new blood vessels, of cancer cells to metastasize, 
                    and of neurons to develop and make proper connections in the 
                    brain. 
                    Two years ago Bokoch and his Scripps Research colleagues 
                    discovered that Rac is one of the master regulators of cell 
                    motilitythe molecules driving the process that places 
                    the cell's "hands" on the steering wheels and "feet" on the 
                    gas pedals. They discovered that Rac is spatially and temporally 
                    regulated during leading-edge extension and tail contraction 
                    during the movement of human neutrophilsthe phagocytic 
                    blood cells that chase down, engulf, and destroy bacterial 
                    pathogens as part of the body's innate immune response. 
                    One of the big questions that remained unanswered, however, 
                    was how Rac was regulated to become active in the first place. 
                    What were the master switches that control the activity of 
                    Rac and the fundamental cell processes it controls? 
                    All that was known until recently was that inside cells, 
                    Rac is controlled by a protein known as RhoGDI, which is in 
                    the cell's cytosol. Rac is inactive in resting cells because 
                    it is bound to RhoGDI. This keeps the Rac in the cytosol and 
                    away from the cellular membrane, where Rac's molecular targets 
                    reside. When the cell receives activation signals, the Rac 
                    GTPases will dissociate from the RhoGDI in the cytosol and 
                    move to the ruffles at the edges of the cell where they are 
                    needed. Thus, Rac must be released from RhoGDI for Rac to 
                    become active. 
                    "Nobody had any idea how this happened," says DerMardirossian. 
                    Now Bokoch, DerMardirossian, and Schnelzer have discovered 
                    the mechanism whereby Rac is released from RhoGDI. In their 
                    current study, they show in vitro and in vivo 
                    that Rac is released from RhoGDI by an enzyme called p21-activated 
                    kinase (Pak). Pak is a kinase enzyme. Its job in the cell 
                    is phosphorylationto attach phosphate groups to other 
                    molecules inside the cells in order to modify their function. 
                    Pak attaches its phosphate to two serine residues within 
                    the portion of RhoGDI that Rac normally binds to. These bulky 
                    and negatively charged phosphates disrupt the normally cozy 
                    bond Rac shares with RhoGDI. Freed from the RhoGDI, Rac can 
                    then become activated and move about the cell to act on its 
                    target molecules and regulate cell function. 
                    Interestingly, one of the targets of active Rac is the enzyme 
                    Pak itself. This suggests that Pak and Rac can participate 
                    in a positive feedback loop whereby active Rac stimulates 
                    Pak, and the active Pak then induces more Rac activation. 
                    Such regulation may be important for maintaining continuous 
                    cell movement. 
                    The article, "Phosphorylation of RhoGDI by Pak1 mediates 
                    dissociation of Rac GTPase" by Celine DerMardirossian, Andreas 
                    Schnelzer, and Gary M. Bokoch appears in the July 2, 2004 
                    issue of the journal Molecular Cell. See http://www.molecule.org. 
                    This work was funded through a grant from the National Institutes 
                    of Health, by a German Academic Exchange fellowship, and by 
                    an American Heart AssociationWestern affiliate fellowship. 
                     Send comments to: jasonb@scripps.edu     
                    
                    
      |